Thrombophilia and pregnancy complications

Hamostaseologie

Volumn 26, Issue 1, 2006, Pages 59-62

  Vormittag, R ^a   Pabinger, Ingrid ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Abortion; Fetal loss; Pre eclampsia; Pregnancy; Thrombophilia; Venous thrombosis

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY;

ANTITHROMBIN DEFICIENCY; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CLINICAL TRIAL; DISEASE ASSOCIATION; GENETIC DISORDER; HUMAN; HYPERHOMOCYSTEINEMIA; MORBIDITY; MORTALITY; MUTATION; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY DISORDER; PREGNANT WOMAN; PREVALENCE; PROSPECTIVE STUDY; PROTEIN S DEFICIENCY; PROTHROMBIN DEFICIENCY; PUERPERIUM; RECURRENCE RISK; REVIEW; RISK FACTOR; THROMBOPHILIA; THROMBOSIS; VENOUS THROMBOEMBOLISM; ARTICLE; FEMALE; SPONTANEOUS ABORTION; THROMBOEMBOLISM;

ABORTION, SPONTANEOUS; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 33645212305     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616879     Document Type: Review

References (25)

1. Bates SM, Greer IA et al. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 Suppl): 627S-44S.
2. Brill-Edwards P, Ginsberg JS et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group. N Engl J Med 2000; 343: 1439-44.
3. Farquharson RG, Quenby S et al. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 2002; 100: 408-13.
4. Galli M, Barbui T. Antiphospholipid antibodies and pregnancy. Best Pract Res Clin Haematol 2003; 16: 211-25.
5. Gerhardt A, Scharf RE et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000; 342: 374-80.
6. Gris JC, Mercier E et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004; 103: 3695-9.
7. Kosmas IP, Tatsioni A et al. Association of Leiden mutation in factor V gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens 2003; 21: 1221-8.
8. Kosmas IP, Tatsioni A et al. Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens 2004; 22: 1655-62.
9. Kupferminc MJ, Eldor A et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 9-13.
10. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174: 1584-9.
11. Lindqvist PG, Svensson PJ et al. Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost 1999; 81: 532-7.
12. McColl MD, Ramsay JE et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 1997; 78: 1183-8.
13. Murphy RP, Donoghue C et al. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy. Arterioscler Thromb Vasc Biol 2000; 20: 266-70.
14. Pabinger I, Grafenhofer H et al. Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. Thromb Haemost 2005 in press.
15. Pabinger I, Grafenhofer H et al. Preeclampsia and fetal loss in women with a history of venous thromboembolism. Arterioscler Thromb Vasc Biol 2001; 21: 874-9.
16. Pabinger I, Grafenhofer H et al. Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood 2002; 100: 1060-2.
17. Pabinger I, Nemes L et al. Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden. Hematol J 2000; 1: 37-41.
18. Pabinger I, Schneider B. Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur Thrombose- und Hämostaseforschung (GTH) Study Group on Natural Inhibitors. Arterioscler Thromb Vasc Biol 1996; 16: 742-8.
19. Preston FE, Rosendaal FR et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996; 348(9032): 913-6.
20. Rai R, Cohen H et al. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J 1997; 314: 253-7.
21. Rai R, Shlebak A et al. Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod 2001; 16: 961-5.
22. Rey E, Kahn SR et al. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003; 361(9361): 901-8.
23. Toglia MR, Weg JG. Venous thromboembolism during pregnancy. N Engl J Med 1996; 335: 108-14.
24. Vossen CY, Preston FE et al. Hereditary thrombophilia and fetal loss: a prospective follow-up study. J Thromb Haemost 2004; 2: 592-6.
25. Younis JS, Brenner B et al. Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss. Am J Reprod Immunol 2000; 43: 31-5.